한글목차

세계 엑소좀 진단, 치료 및 연구 툴 시장 규모는 2023년 2억 2,750만 달러에서 예측 기간 동안 42.2%의 CAGR을 기록하며 2028년에는 13억 달러 규모로 성장할 것으로 예상됩니다.

연구 툴 및 시약 부문은 2023년 1억 3,720만 달러에서 2028년 3억 5,270만 달러로 2028년까지 연평균 20.8% 성장할 것으로 예측됩니다. 진단 및 모니터링 부문은 2023년 9,030만 달러에서 연평균 48.6% 성장하여 2028년에는 6억 5,430만 달러에 달할 것으로 예상됩니다.

세계 엑소좀 진단, 치료, 연구 툴 시장을 조사했으며, 시장 개요, 규제 환경, 시장 영향요인 및 시장 기회 분석, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약

제2장 시장 개요

• 엑소좀 기초
• 엑소좀 생물 발생과 처리
• 엑소좀 기능과 생리학
• 세포내 커뮤니케이션
• 면역 반응 촉진
• 조직 재생
• 엑소좀 연구 및 제품 개발을 위한 바이오인포매틱스 데이터베이스
• ExoCarta
• Vesiclepedia
• EVpedia

제3장 시장 역학

• 개요
• 시장 성장 촉진요인
• 바이오메디컬 연구에 대한 투자 증가
• 정밀의료에 대한 동향
• 엑소좀 연구 툴의 기술적 진보
• 성장 억제요인
• 진화하는 규제 상황
• 잘 특성화된 엑소좀 표준물질의 결여
• 기회
• 액체 생검의 인기 상승
• 줄기세포 치료보다 우수한 이점
• 과제
• 자금 조달 문제

제4장 규제 상황

• 미국
• 엑소좀 치료
• 엑소좀 임상 어세이 개발과 마케팅

제5장 신기술과 개발

• 신기술
• 인공 엑소좀
• 마이크로플루이딕스 기술
• 엑소좀 연구 서비스
• 엑소좀 기반 액체 생검 검사
• 임상시험 분석
• 파이프라인 분석

제6장 시장 분석 : 각종 부문별

• 분류 내역
• 시장 분석 : 용도별
• 진단·모니터링
• 진단·모니터링 시장 평가
• 암
• 중추신경계 질환·신경변성질환
• 장기 이식
• 심혈관질환
• 기타
• 진단·모니터링 시장 매출
• 엑소좀 치료
• 잠재적 치료에 대한 응용
• 현재 치료제 시장과 잠재적 치료제 시장 평가
• 주요 적응증
• 연구 툴·시약
• 연구 툴·시약 시장 매출
• 시장 분석 : 지역적
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제7장 경쟁 정보

• 개요
• 엑소좀 기반 임상 진단 시장
• 엑소좀 기반 임상 진단 시장 : 시장 진출 기업
• 엑소좀 기반 치료제 시장
• 엑소좀 기반 치료제 시장 : 시장 진출 기업
• 엑소좀 연구 툴·시약 시장
• 엑소좀 연구 툴·시약 시장 : 시장 진출 기업
• 주요 전략
• 엑소좀 시장의 기회와 과제

제8장 부록

• 조사 방법
• 정보 출처/참고문헌
• 두문자어
• 기업 개요
• ACOUSORT AB
• AEGLE THERAPEUTICS
• AETHLON MEDICAL INC.
• ARUNA BIO INC.
• BIO-TECHNE
• CAPRICOR THERAPEUTICS INC.
• CARIS LIFE SCIENCES
• DIRECT BIOLOGICS LLC
• EXOSOMICS SPA
• EVOX THERAPEUTICS LTD.
• KIMERA LABS
• LONZA
• MIR SCIENTIFIC
• NANO MED
• NANOSOMIX
• RION
• SYSTEM BIOSCIENCES LLC

영문목차

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

The global market for research tools and reagents in exosome diagnostics, therapeutics and research tools is estimated to increase from $137.2 million in 2023 to reach $352.7 million by 2028, at a CAGR of 20.8% from 2023 through 2028.

The global market for diagnostics and monitoring in exosome diagnostics, therapeutics and research tools is estimated to increase from $90.3 million in 2023 to reach $654.3 million by 2028, at a CAGR of 48.6% from 2023 through 2028.

Report Scope

This report aims to provide a comprehensive study of the global market for exosome diagnostic, therapeutic, and research tools, both in terms of quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the base year) and forecasts values for 2023 through 2028.

The scope of this study is global and covers exosome products and research tools used in the healthcare industry only. Exosome products and research tools used in other sectors, such as skincare and beauty, are beyond the scope of this report.

Report Includes

• 14 data tables and 77 additional tables
• Analysis of the global markets and global trends for exosome diagnostics and therapeutics, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
• Estimate of the current market size and revenue growth prospects, along with a market share analysis based on product, application, end user and region
• Facts and figures pertaining to the market drivers, opportunities and restraints, and the impacts of macroeconomic variables
• Discussion of emerging technologies, regulations and R&D efforts
• Evaluation of new commercial opportunities in the diagnostics, therapeutics and research tools markets, and an assessment of trends, products and assay developments
• Insight into the use of exosome proteins and nucleic acids as diagnostic biomarkers and their impact on the microRNA, liquid biopsy and stem cell research industry
• Analysis of relevant patents related to exosome diagnostics and therapeutics in the U.S., Europe and Japan
• Overview of sustainability trends and ESG developments, including consumer attitudes, companies' ESG score rankings and their ESG practices
• Analysis of the competitive landscape, including companies' market shares, business segments, financials and product portfolios, as well as recent M&A activity and a venture funding outlook
• Company profiles of major players within the industry, including Bio-Techne, Exosomics S.p.A., and System Biosciences LLC.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Exosome Basics
• Exosome Biogenesis and Processing
• Exosome Function and Physiology
• Intracellular Communication
• Facilitation of the Immune Response
• Tissue Regeneration
• Bioinformatic Databases for Exosome Research and Product Development
• ExoCarta
• Vesiclepedia
• EVpedia

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Investment in Biomedical Research
• Trend Towards Precision Medicine
• Technological Advancements in Exosome Research Tools
• Restraints
• Evolving Regulatory Landscape
• Lack of Well-Characterized Exosome Standards
• Opportunities
• Growing Popularity in Liquid Biopsy
• Benefits Over Stem Cell Therapy
• Challenges
• Funding Issues

Chapter 4 Regulatory Landscape

• U.S.
• Exosome Therapeutics
• Exosome Clinical Assays Development and Marketing

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Engineered Exosomes
• Microfluidic Technology
• Exosome Research Services
• Exosome Based Liquid Biopsy Tests
• Clinical Trial Analysis
• Overview
• By Phases
• By Funder Type
• By Disease Type
• By Country
• Pipeline Analysis

Chapter 6 Market Segmentation Analysis

• Segmental Breakdown
• Market Analysis by Application Type
• Diagnostics and Monitoring
• Evaluation of the Diagnostics and Monitoring Market
• Cancer
• CNS Disorders and Neurodegeneration Diseases
• Organ Transplantation
• Cardiovascular Diseases
• Others
• Diagnostics and Monitoring Market Revenue
• Exosome Therapeutics
• Potential Therapeutic Applications
• Evaluation of the Current and Potential Therapeutics Market
• Key Target Indications
• Research Tools and Regents
• Research Tools and Reagents Market Revenue
• Geographic Breakdown
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Overview
• Exosome-Based Clinical Diagnostics Market
• Market Participants in the Exosome-Based Clinical Diagnostics Market
• Exosome-Based Therapeutics Market
• Market Participants in the Exosome-Based Therapeutics Market
• Exosome Research Tools and Reagents Market
• Market Participants in the Exosome Research Tools and Reagents Market
• Key Strategies
• Opportunities and Challenges in the Exosome Market

Chapter 8 Appendix

• Methodology
• Sources/References
• Acronyms
• Company Profiles
• ACOUSORT AB
• AEGLE THERAPEUTICS
• AETHLON MEDICAL INC.
• ARUNA BIO INC.
• BIO-TECHNE
• CAPRICOR THERAPEUTICS INC.
• CARIS LIFE SCIENCES
• DIRECT BIOLOGICS LLC
• EXOSOMICS SPA
• EVOX THERAPEUTICS LTD.
• KIMERA LABS
• LONZA
• MIR SCIENTIFIC
• NANO MED
• NANOSOMIX
• RION
• SYSTEM BIOSCIENCES LLC